Xu Y, Huang L, Wang J, He J, Wang Y, Zhang W
BMC Cancer. 2024; 24(1):1387.
PMID: 39533204
PMC: 11556076.
DOI: 10.1186/s12885-024-13156-y.
Hata N, Ihara T
Acute Med Surg. 2024; 11(1):e70012.
PMID: 39507319
PMC: 11538900.
DOI: 10.1002/ams2.70012.
Nazer L, Awad W, Thawabieh H, AbuSara A, Abdelrahman D, Addassi A
Crit Care Explor. 2024; 6(10):e1173.
PMID: 39431961
PMC: 11495690.
DOI: 10.1097/CCE.0000000000001173.
Qin Y, Lu S, Chen J, Peng J, Yang J
Front Oncol. 2024; 14:1415748.
PMID: 38957321
PMC: 11217477.
DOI: 10.3389/fonc.2024.1415748.
Babakhanlou R, Ravandi-Kashani F, Hita A, Kontoyiannis D
J Hematol. 2024; 13(1-2):1-11.
PMID: 38644983
PMC: 11027774.
DOI: 10.14740/jh1251.
Efficacy and Safety of Oral and IV Levonadifloxacin Therapy in Management of Bacterial Infections: Findings of a Prospective, Observational, Multi-center, Post-marketing Surveillance Study.
Saseedharan S, Zirpe K, Mehta Y, Dubey D, Sutar A, Debnath K
Cureus. 2024; 16(2):e55178.
PMID: 38558736
PMC: 10980586.
DOI: 10.7759/cureus.55178.
Fever of unknown origin associated with immune checkpoint inhibitors.
Tong X, Zhan T, Dong X, Xu D
Front Immunol. 2024; 15:1364128.
PMID: 38533499
PMC: 10963505.
DOI: 10.3389/fimmu.2024.1364128.
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT.
Coyle V, Forde C, Adams R, Agus A, Barnes R, Chau I
Health Technol Assess. 2024; 28(14):1-101.
PMID: 38512064
PMC: 11017157.
DOI: 10.3310/RGTP7112.
The Use of Granulocyte Colony-Stimulating Factor as Primary Prophylaxis in Patients Undergoing Chemotherapy: An Experience of Moroccan Oncologists.
Kaakoua M, Boujmadi S, Belbaraka R, Essadi I
Cureus. 2024; 16(2):e54482.
PMID: 38510886
PMC: 10954314.
DOI: 10.7759/cureus.54482.
Evaluation of antibiotic resistance, toxin-antitoxin systems, virulence factors, biofilm-forming strength and genetic linkage of Escherichia coli strains isolated from bloodstream infections of leukemia patients.
Roshani M, Taheri M, Goodarzi A, Yosefimashouf R, Shokoohizadeh L
BMC Microbiol. 2023; 23(1):327.
PMID: 37925405
PMC: 10625236.
DOI: 10.1186/s12866-023-03081-8.
Microbiological Spectrum of Neutropenic Sepsis in Cancer Patients Admitted to a Tertiary Health Care Centre.
John K, Warrier A, Warrier A
Cureus. 2023; 15(8):e43898.
PMID: 37746392
PMC: 10515477.
DOI: 10.7759/cureus.43898.
All-Cause Mortality and Its Predictors in Haemato-Oncology Patients with Febrile Neutropenia.
Shmuely H, Monely L, Shvidel L
J Clin Med. 2023; 12(17).
PMID: 37685702
PMC: 10489066.
DOI: 10.3390/jcm12175635.
Antibiotic prescribing behavior among physicians in Asia: a multinational survey.
Wiboonchutikula C, Kim H, Honda H, Xin Loo A, Cheng V, Camins B
Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e112.
PMID: 37502240
PMC: 10369444.
DOI: 10.1017/ash.2023.190.
Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults.
Weller M, Le Rhun E, van den Bent M, Chang S, Cloughesy T, Goldbrunner R
Neuro Oncol. 2023; 25(7):1200-1224.
PMID: 36843451
PMC: 10326495.
DOI: 10.1093/neuonc/noad038.
Common oncologic emergencies.
Regnier L, Wilkinson A
Can Fam Physician. 2023; 69(1):28-32.
PMID: 36693744
PMC: 9873297.
DOI: 10.46747/cfp.690128.
Catheter-related bloodstream infection caused by in a pediatric oncology patient.
Kandemir O, Erbey F, Asarcikli F, Oflaz Sozmen B, Ozen M, Akturk H
Germs. 2022; 12(2):316-317.
PMID: 36504612
PMC: 9719382.
DOI: 10.18683/germs.2022.1335.
The Prognostic Utility of Lymphocyte-Based Measures and Ratios in Chemotherapy-Induced Febrile Neutropenia Patients following Granulocyte Colony-Stimulating Factor Therapy.
Halalsheh O, Al Zubi Y, Al Sharie A, Wafai F, Alabdallah N, AlSeidi J
Medicina (Kaunas). 2022; 58(11).
PMID: 36363465
PMC: 9695543.
DOI: 10.3390/medicina58111508.
Microbial and host factors contribute to bloodstream infection in a pediatric acute lymphocytic leukemia mouse model.
Song Y, Perlman K, Gyarmati P
Heliyon. 2022; 8(11):e11340.
PMID: 36345525
PMC: 9636473.
DOI: 10.1016/j.heliyon.2022.e11340.
Effects of primary granulocyte-colony stimulating factor prophylaxis on the incidence of febrile neutropenia in patients with germ cell tumors.
Hapakova N, Chovanec M, Rejlekova K, Kalavska K, Obertova J, Palacka P
Oncol Lett. 2022; 24(3):308.
PMID: 35949605
PMC: 9353223.
DOI: 10.3892/ol.2022.13428.
Usability Evaluation of a Noninvasive Neutropenia Screening Device (PointCheck) for Patients Undergoing Cancer Chemotherapy: Mixed Methods Observational Study.
Lamaj G, Pablo-Trinidad A, Butterworth I, Bell N, Benasutti R, Bourquard A
J Med Internet Res. 2022; 24(8):e37368.
PMID: 35943786
PMC: 9621111.
DOI: 10.2196/37368.